Tags

Type your tag names separated by a space and hit enter

Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Drug Alcohol Rev. 2007 May; 26(3):231-9.DA

Abstract

Amongst people on opioid maintenance treatment (OMT), chronic hepatitis C (HCV) is common but infrequently treated. Numerous barriers, including misuse of alcohol may limit efforts at anti-viral treatment. The aim of this study was to define barriers, including alcohol misuse, to the effective treatment of HCV amongst OMT recipients. Ninety-four OMT patients completed the 3-item Alcohol Use Disorders Identification Test (AUDIT-C). A semi-structured interview was used in 53 subjects to assess alcohol use in detail, psychological health, discrimination and access to HCV treatment. Feasibility of brief intervention for alcohol misuse was assessed. Of the screening participants, 73% reported they were HCV positive. Of the detailed interview participants, 26% reported no drinking in the past month, but 53% scored 8 or more on AUDIT and 42% exceeded NHMRC drinking guidelines. Twenty subjects received brief intervention and among 17 re-interviewed at one month, alcohol consumption fell by 3.1 g/day (p = 0.003). Severe or extremely severe depression, stress and anxiety were found in 57%, 51% and 40% of interviewees respectively. Episodic heavy drinking, mental health problems, perceived discrimination, limited knowledge concerning HCV were all common and uptake of HCV treatment was poor. Brief intervention for alcohol use problems was acceptable to OMT patients, and warrants further study.

Authors+Show Affiliations

Royal Prince Alfred Hospital, Sydney, Australia.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17454012

Citation

Watson, Bianca, et al. "Hazardous Alcohol Consumption and Other Barriers to Antiviral Treatment Among Hepatitis C Positive People Receiving Opioid Maintenance Treatment." Drug and Alcohol Review, vol. 26, no. 3, 2007, pp. 231-9.
Watson B, Conigrave KM, Wallace C, et al. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug Alcohol Rev. 2007;26(3):231-9.
Watson, B., Conigrave, K. M., Wallace, C., Whitfield, J. B., Wurst, F., & Haber, P. S. (2007). Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review, 26(3), 231-9.
Watson B, et al. Hazardous Alcohol Consumption and Other Barriers to Antiviral Treatment Among Hepatitis C Positive People Receiving Opioid Maintenance Treatment. Drug Alcohol Rev. 2007;26(3):231-9. PubMed PMID: 17454012.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. AU - Watson,Bianca, AU - Conigrave,Katherine M, AU - Wallace,Cate, AU - Whitfield,John B, AU - Wurst,Friedrich, AU - Haber,Paul S, PY - 2007/4/25/pubmed PY - 2007/8/2/medline PY - 2007/4/25/entrez SP - 231 EP - 9 JF - Drug and alcohol review JO - Drug Alcohol Rev VL - 26 IS - 3 N2 - Amongst people on opioid maintenance treatment (OMT), chronic hepatitis C (HCV) is common but infrequently treated. Numerous barriers, including misuse of alcohol may limit efforts at anti-viral treatment. The aim of this study was to define barriers, including alcohol misuse, to the effective treatment of HCV amongst OMT recipients. Ninety-four OMT patients completed the 3-item Alcohol Use Disorders Identification Test (AUDIT-C). A semi-structured interview was used in 53 subjects to assess alcohol use in detail, psychological health, discrimination and access to HCV treatment. Feasibility of brief intervention for alcohol misuse was assessed. Of the screening participants, 73% reported they were HCV positive. Of the detailed interview participants, 26% reported no drinking in the past month, but 53% scored 8 or more on AUDIT and 42% exceeded NHMRC drinking guidelines. Twenty subjects received brief intervention and among 17 re-interviewed at one month, alcohol consumption fell by 3.1 g/day (p = 0.003). Severe or extremely severe depression, stress and anxiety were found in 57%, 51% and 40% of interviewees respectively. Episodic heavy drinking, mental health problems, perceived discrimination, limited knowledge concerning HCV were all common and uptake of HCV treatment was poor. Brief intervention for alcohol use problems was acceptable to OMT patients, and warrants further study. SN - 0959-5236 UR - https://www.unboundmedicine.com/medline/citation/17454012/Hazardous_alcohol_consumption_and_other_barriers_to_antiviral_treatment_among_hepatitis_C_positive_people_receiving_opioid_maintenance_treatment_ L2 - https://doi.org/10.1080/09595230701247681 DB - PRIME DP - Unbound Medicine ER -